医学
萧条(经济学)
酒精使用障碍
双重诊断
精神科
对偶(语法数字)
酒
药物滥用
生物化学
文学类
宏观经济学
艺术
经济
化学
作者
Yury P. Sivolap,Evgeny Krupitsky,В. Д. Менделевич,К. В. Рыбакова,М.А. Винникова,A. Yu. Egorov,G. M. Usov
出处
期刊:Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova
[Media Sphera Publishing Group]
日期:2021-01-01
卷期号:121 (7): 135-135
被引量:5
标识
DOI:10.17116/jnevro2021121071135
摘要
A combination of depression and alcohol use disorder (AUD) is a typical and most common example of a dual diagnosis at the intersection of general psychiatry and addiction psychiatry. A comorbidity of depression and AUD is more common than it can be brought about by mere coincidence, which might be explained to some extent by the synergetic effect of both diseases, with each of them complicating the course and worsening the prognosis of the other. Treatment protocols for patients with depression and comorbid AUD include antidepressants, specific medications for alcohol dependence, and psychotherapy. The first-line antidepressants in the treatment of patients with a comorbid combination of depression and alcohol use disorder, as in other clinical situations implying use of antidepressants, are selective serotonin reuptake inhibitors (SSRIs). Fluvoxamine has certain advantages over the other SSRIs in the treatment of patients with a depression and comorbid AUD.
科研通智能强力驱动
Strongly Powered by AbleSci AI